Adverse Drug Reactions After Administration of Emodepside/Praziquantel (Profender®) in an MDR1-Mutant Australian Shepherd Dog: Case Report

Evaluation of emodepside in laboratory models of human intestinal nematode and schistosome infections

(2019) Tanja Karpstein et al.   Parasites & Vectors

The Effect of the CanineABCB1-1Δ Mutation on Sedation after Intravenous Administration of Acepromazine

(2016) D. Deshpande et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

The Cyclooctadepsipeptide Anthelmintic Emodepside Differentially Modulates Nematode, Insect and Human Calcium-Activated Potassium (SLO) Channel Alpha Subunits

(2015) Anna Crisford et al.   PLoS Neglected Tropical Diseases

Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis

(2014) S. Elmshäuser et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

New advancement in anthelmintic drugs in veterinary medicine

(2013) Christian Epe et al.   TRENDS IN PARASITOLOGY

Decreased emodepside sensitivity in unc-49 γ-aminobutyric acid (GABA)-receptor-deficient Caenorhabditis elegans

(2012) Sandra M. Miltsch et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Worms take to the slo lane: a perspective on the mode of action of emodepside

(2012) Lindy Holden-Dye et al.   INVERTEBRATE NEUROSCIENCE

Anthelmintic cyclooctadepsipeptides: complex in structure and mode of action

(2012) Jürgen Krücken et al.   TRENDS IN PARASITOLOGY

Selective Toxicity of the Anthelmintic Emodepside Revealed by Heterologous Expression of Human KCNMA1 in Caenorhabditis elegans

(2011) A. Crisford et al.   MOLECULAR PHARMACOLOGY

Breed distribution of the nt230(del4) MDR1 mutation in dogs

(2010) Irina Gramer et al.   VETERINARY JOURNAL

Effects of the anthelmintic drug PF1022A on mammalian tissue and cells

(2009) R. Dornetshuber et al.   BIOCHEMICAL PHARMACOLOGY